[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Antibody Development Services Market, Global Outlook and Forecast 2022-2028

June 2022 | 118 pages | ID: A07C45798E89EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Antibody Development Services in Global, including the following market information:

Global Antibody Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Antibody Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Monoclonal Antibody Development Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Antibody Development Services include Thermo Fisher Scientific, R&D Systems, Leinco Technologies, Rockland Immunochemicals, Inc. (Rockland), Bio-Rad, BioGenes, ProteoGenix, Labcorp and Inotiv, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibody Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Antibody Development Services Market Segment Percentages, by Type, 2021 (%)
  • Monoclonal Antibody Development
  • Polyclonal Antibody Development
Global Antibody Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Antibody Development Services Market Segment Percentages, by Application, 2021 (%)
  • Medical Industry
  • Biological Industry
  • Others
Global Antibody Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Antibody Development Services Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antibody Development Services revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Antibody Development Services revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Thermo Fisher Scientific
  • R&D Systems
  • Leinco Technologies
  • Rockland Immunochemicals, Inc. (Rockland)
  • Bio-Rad
  • BioGenes
  • ProteoGenix
  • Labcorp
  • Inotiv, Inc.
  • ProMab Biotechnologies
  • Kemp Proteins
  • Synaptic Systems
  • ARVYS Proteins, Inc.
  • BBI Solutions
  • Innovagen AB
  • BIOTEM
  • Medimab
  • OriGene
  • Abeomics Inc.
  • RayBiotech
  • Genscript Biotech Corporation
  • Sino Biological
  • Abzena Ltd
  • Creative Biolabs
  • Abcam
  • Antibodies Incorporated
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibody Development Services Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibody Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODY DEVELOPMENT SERVICES OVERALL MARKET SIZE

2.1 Global Antibody Development Services Market Size: 2021 VS 2028
2.2 Global Antibody Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibody Development Services Players in Global Market
3.2 Top Global Antibody Development Services Companies Ranked by Revenue
3.3 Global Antibody Development Services Revenue by Companies
3.4 Top 3 and Top 5 Antibody Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Antibody Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibody Development Services Players in Global Market
  3.6.1 List of Global Tier 1 Antibody Development Services Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibody Development Services Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Antibody Development Services Market Size Markets, 2021 & 2028
  4.1.2 Monoclonal Antibody Development
  4.1.3 Polyclonal Antibody Development
4.2 By Type - Global Antibody Development Services Revenue & Forecasts
  4.2.1 By Type - Global Antibody Development Services Revenue, 2017-2022
  4.2.2 By Type - Global Antibody Development Services Revenue, 2023-2028
  4.2.3 By Type - Global Antibody Development Services Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibody Development Services Market Size, 2021 & 2028
  5.1.2 Medical Industry
  5.1.3 Biological Industry
  5.1.4 Others
5.2 By Application - Global Antibody Development Services Revenue & Forecasts
  5.2.1 By Application - Global Antibody Development Services Revenue, 2017-2022
  5.2.2 By Application - Global Antibody Development Services Revenue, 2023-2028
  5.2.3 By Application - Global Antibody Development Services Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Antibody Development Services Market Size, 2021 & 2028
6.2 By Region - Global Antibody Development Services Revenue & Forecasts
  6.2.1 By Region - Global Antibody Development Services Revenue, 2017-2022
  6.2.2 By Region - Global Antibody Development Services Revenue, 2023-2028
  6.2.3 By Region - Global Antibody Development Services Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Antibody Development Services Revenue, 2017-2028
  6.3.2 US Antibody Development Services Market Size, 2017-2028
  6.3.3 Canada Antibody Development Services Market Size, 2017-2028
  6.3.4 Mexico Antibody Development Services Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Antibody Development Services Revenue, 2017-2028
  6.4.2 Germany Antibody Development Services Market Size, 2017-2028
  6.4.3 France Antibody Development Services Market Size, 2017-2028
  6.4.4 U.K. Antibody Development Services Market Size, 2017-2028
  6.4.5 Italy Antibody Development Services Market Size, 2017-2028
  6.4.6 Russia Antibody Development Services Market Size, 2017-2028
  6.4.7 Nordic Countries Antibody Development Services Market Size, 2017-2028
  6.4.8 Benelux Antibody Development Services Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Antibody Development Services Revenue, 2017-2028
  6.5.2 China Antibody Development Services Market Size, 2017-2028
  6.5.3 Japan Antibody Development Services Market Size, 2017-2028
  6.5.4 South Korea Antibody Development Services Market Size, 2017-2028
  6.5.5 Southeast Asia Antibody Development Services Market Size, 2017-2028
  6.5.6 India Antibody Development Services Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Antibody Development Services Revenue, 2017-2028
  6.6.2 Brazil Antibody Development Services Market Size, 2017-2028
  6.6.3 Argentina Antibody Development Services Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibody Development Services Revenue, 2017-2028
  6.7.2 Turkey Antibody Development Services Market Size, 2017-2028
  6.7.3 Israel Antibody Development Services Market Size, 2017-2028
  6.7.4 Saudi Arabia Antibody Development Services Market Size, 2017-2028
  6.7.5 UAE Antibody Development Services Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Antibody Development Services Major Product Offerings
  7.1.4 Thermo Fisher Scientific Antibody Development Services Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 R&D Systems
  7.2.1 R&D Systems Corporate Summary
  7.2.2 R&D Systems Business Overview
  7.2.3 R&D Systems Antibody Development Services Major Product Offerings
  7.2.4 R&D Systems Antibody Development Services Revenue in Global Market (2017-2022)
  7.2.5 R&D Systems Key News
7.3 Leinco Technologies
  7.3.1 Leinco Technologies Corporate Summary
  7.3.2 Leinco Technologies Business Overview
  7.3.3 Leinco Technologies Antibody Development Services Major Product Offerings
  7.3.4 Leinco Technologies Antibody Development Services Revenue in Global Market (2017-2022)
  7.3.5 Leinco Technologies Key News
7.4 Rockland Immunochemicals, Inc. (Rockland)
  7.4.1 Rockland Immunochemicals, Inc. (Rockland) Corporate Summary
  7.4.2 Rockland Immunochemicals, Inc. (Rockland) Business Overview
  7.4.3 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Major Product Offerings
  7.4.4 Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue in Global Market (2017-2022)
  7.4.5 Rockland Immunochemicals, Inc. (Rockland) Key News
7.5 Bio-Rad
  7.5.1 Bio-Rad Corporate Summary
  7.5.2 Bio-Rad Business Overview
  7.5.3 Bio-Rad Antibody Development Services Major Product Offerings
  7.5.4 Bio-Rad Antibody Development Services Revenue in Global Market (2017-2022)
  7.5.5 Bio-Rad Key News
7.6 BioGenes
  7.6.1 BioGenes Corporate Summary
  7.6.2 BioGenes Business Overview
  7.6.3 BioGenes Antibody Development Services Major Product Offerings
  7.6.4 BioGenes Antibody Development Services Revenue in Global Market (2017-2022)
  7.6.5 BioGenes Key News
7.7 ProteoGenix
  7.7.1 ProteoGenix Corporate Summary
  7.7.2 ProteoGenix Business Overview
  7.7.3 ProteoGenix Antibody Development Services Major Product Offerings
  7.7.4 ProteoGenix Antibody Development Services Revenue in Global Market (2017-2022)
  7.7.5 ProteoGenix Key News
7.8 Labcorp
  7.8.1 Labcorp Corporate Summary
  7.8.2 Labcorp Business Overview
  7.8.3 Labcorp Antibody Development Services Major Product Offerings
  7.8.4 Labcorp Antibody Development Services Revenue in Global Market (2017-2022)
  7.8.5 Labcorp Key News
7.9 Inotiv, Inc.
  7.9.1 Inotiv, Inc. Corporate Summary
  7.9.2 Inotiv, Inc. Business Overview
  7.9.3 Inotiv, Inc. Antibody Development Services Major Product Offerings
  7.9.4 Inotiv, Inc. Antibody Development Services Revenue in Global Market (2017-2022)
  7.9.5 Inotiv, Inc. Key News
7.10 ProMab Biotechnologies
  7.10.1 ProMab Biotechnologies Corporate Summary
  7.10.2 ProMab Biotechnologies Business Overview
  7.10.3 ProMab Biotechnologies Antibody Development Services Major Product Offerings
  7.10.4 ProMab Biotechnologies Antibody Development Services Revenue in Global Market (2017-2022)
  7.10.5 ProMab Biotechnologies Key News
7.11 Kemp Proteins
  7.11.1 Kemp Proteins Corporate Summary
  7.11.2 Kemp Proteins Business Overview
  7.11.3 Kemp Proteins Antibody Development Services Major Product Offerings
  7.11.4 Kemp Proteins Antibody Development Services Revenue in Global Market (2017-2022)
  7.11.5 Kemp Proteins Key News
7.12 Synaptic Systems
  7.12.1 Synaptic Systems Corporate Summary
  7.12.2 Synaptic Systems Business Overview
  7.12.3 Synaptic Systems Antibody Development Services Major Product Offerings
  7.12.4 Synaptic Systems Antibody Development Services Revenue in Global Market (2017-2022)
  7.12.5 Synaptic Systems Key News
7.13 ARVYS Proteins, Inc.
  7.13.1 ARVYS Proteins, Inc. Corporate Summary
  7.13.2 ARVYS Proteins, Inc. Business Overview
  7.13.3 ARVYS Proteins, Inc. Antibody Development Services Major Product Offerings
  7.13.4 ARVYS Proteins, Inc. Antibody Development Services Revenue in Global Market (2017-2022)
  7.13.5 ARVYS Proteins, Inc. Key News
7.14 BBI Solutions
  7.14.1 BBI Solutions Corporate Summary
  7.14.2 BBI Solutions Business Overview
  7.14.3 BBI Solutions Antibody Development Services Major Product Offerings
  7.14.4 BBI Solutions Antibody Development Services Revenue in Global Market (2017-2022)
  7.14.5 BBI Solutions Key News
7.15 Innovagen AB
  7.15.1 Innovagen AB Corporate Summary
  7.15.2 Innovagen AB Business Overview
  7.15.3 Innovagen AB Antibody Development Services Major Product Offerings
  7.15.4 Innovagen AB Antibody Development Services Revenue in Global Market (2017-2022)
  7.15.5 Innovagen AB Key News
7.16 BIOTEM
  7.16.1 BIOTEM Corporate Summary
  7.16.2 BIOTEM Business Overview
  7.16.3 BIOTEM Antibody Development Services Major Product Offerings
  7.16.4 BIOTEM Antibody Development Services Revenue in Global Market (2017-2022)
  7.16.5 BIOTEM Key News
7.17 Medimab
  7.17.1 Medimab Corporate Summary
  7.17.2 Medimab Business Overview
  7.17.3 Medimab Antibody Development Services Major Product Offerings
  7.17.4 Medimab Antibody Development Services Revenue in Global Market (2017-2022)
  7.17.5 Medimab Key News
7.18 OriGene
  7.18.1 OriGene Corporate Summary
  7.18.2 OriGene Business Overview
  7.18.3 OriGene Antibody Development Services Major Product Offerings
  7.18.4 OriGene Antibody Development Services Revenue in Global Market (2017-2022)
  7.18.5 OriGene Key News
7.19 Abeomics Inc.
  7.19.1 Abeomics Inc. Corporate Summary
  7.19.2 Abeomics Inc. Business Overview
  7.19.3 Abeomics Inc. Antibody Development Services Major Product Offerings
  7.19.4 Abeomics Inc. Antibody Development Services Revenue in Global Market (2017-2022)
  7.19.5 Abeomics Inc. Key News
7.20 RayBiotech
  7.20.1 RayBiotech Corporate Summary
  7.20.2 RayBiotech Business Overview
  7.20.3 RayBiotech Antibody Development Services Major Product Offerings
  7.20.4 RayBiotech Antibody Development Services Revenue in Global Market (2017-2022)
  7.20.5 RayBiotech Key News
7.21 Genscript Biotech Corporation
  7.21.1 Genscript Biotech Corporation Corporate Summary
  7.21.2 Genscript Biotech Corporation Business Overview
  7.21.3 Genscript Biotech Corporation Antibody Development Services Major Product Offerings
  7.21.4 Genscript Biotech Corporation Antibody Development Services Revenue in Global Market (2017-2022)
  7.21.5 Genscript Biotech Corporation Key News
7.22 Sino Biological
  7.22.1 Sino Biological Corporate Summary
  7.22.2 Sino Biological Business Overview
  7.22.3 Sino Biological Antibody Development Services Major Product Offerings
  7.22.4 Sino Biological Antibody Development Services Revenue in Global Market (2017-2022)
  7.22.5 Sino Biological Key News
7.23 Abzena Ltd
  7.23.1 Abzena Ltd Corporate Summary
  7.23.2 Abzena Ltd Business Overview
  7.23.3 Abzena Ltd Antibody Development Services Major Product Offerings
  7.23.4 Abzena Ltd Antibody Development Services Revenue in Global Market (2017-2022)
  7.23.5 Abzena Ltd Key News
7.24 Creative Biolabs
  7.24.1 Creative Biolabs Corporate Summary
  7.24.2 Creative Biolabs Business Overview
  7.24.3 Creative Biolabs Antibody Development Services Major Product Offerings
  7.24.4 Creative Biolabs Antibody Development Services Revenue in Global Market (2017-2022)
  7.24.5 Creative Biolabs Key News
7.25 Abcam
  7.25.1 Abcam Corporate Summary
  7.25.2 Abcam Business Overview
  7.25.3 Abcam Antibody Development Services Major Product Offerings
  7.25.4 Abcam Antibody Development Services Revenue in Global Market (2017-2022)
  7.25.5 Abcam Key News
7.26 Antibodies Incorporated
  7.26.1 Antibodies Incorporated Corporate Summary
  7.26.2 Antibodies Incorporated Business Overview
  7.26.3 Antibodies Incorporated Antibody Development Services Major Product Offerings
  7.26.4 Antibodies Incorporated Antibody Development Services Revenue in Global Market (2017-2022)
  7.26.5 Antibodies Incorporated Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Antibody Development Services Market Opportunities & Trends in Global Market
Table 2. Antibody Development Services Market Drivers in Global Market
Table 3. Antibody Development Services Market Restraints in Global Market
Table 4. Key Players of Antibody Development Services in Global Market
Table 5. Top Antibody Development Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Antibody Development Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Antibody Development Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Antibody Development Services Product Type
Table 9. List of Global Tier 1 Antibody Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibody Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Antibody Development Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Antibody Development Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Antibody Development Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Antibody Development Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Antibody Development Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Antibody Development Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Antibody Development Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Antibody Development Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Antibody Development Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Antibody Development Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Antibody Development Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Antibody Development Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Antibody Development Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Antibody Development Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Antibody Development Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Antibody Development Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Antibody Development Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Antibody Development Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Antibody Development Services Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Antibody Development Services Product Offerings
Table 32. Thermo Fisher Scientific Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 33. R&D Systems Corporate Summary
Table 34. R&D Systems Antibody Development Services Product Offerings
Table 35. R&D Systems Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 36. Leinco Technologies Corporate Summary
Table 37. Leinco Technologies Antibody Development Services Product Offerings
Table 38. Leinco Technologies Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 39. Rockland Immunochemicals, Inc. (Rockland) Corporate Summary
Table 40. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Product Offerings
Table 41. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 42. Bio-Rad Corporate Summary
Table 43. Bio-Rad Antibody Development Services Product Offerings
Table 44. Bio-Rad Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 45. BioGenes Corporate Summary
Table 46. BioGenes Antibody Development Services Product Offerings
Table 47. BioGenes Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 48. ProteoGenix Corporate Summary
Table 49. ProteoGenix Antibody Development Services Product Offerings
Table 50. ProteoGenix Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 51. Labcorp Corporate Summary
Table 52. Labcorp Antibody Development Services Product Offerings
Table 53. Labcorp Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 54. Inotiv, Inc. Corporate Summary
Table 55. Inotiv, Inc. Antibody Development Services Product Offerings
Table 56. Inotiv, Inc. Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 57. ProMab Biotechnologies Corporate Summary
Table 58. ProMab Biotechnologies Antibody Development Services Product Offerings
Table 59. ProMab Biotechnologies Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 60. Kemp Proteins Corporate Summary
Table 61. Kemp Proteins Antibody Development Services Product Offerings
Table 62. Kemp Proteins Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 63. Synaptic Systems Corporate Summary
Table 64. Synaptic Systems Antibody Development Services Product Offerings
Table 65. Synaptic Systems Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 66. ARVYS Proteins, Inc. Corporate Summary
Table 67. ARVYS Proteins, Inc. Antibody Development Services Product Offerings
Table 68. ARVYS Proteins, Inc. Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 69. BBI Solutions Corporate Summary
Table 70. BBI Solutions Antibody Development Services Product Offerings
Table 71. BBI Solutions Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 72. Innovagen AB Corporate Summary
Table 73. Innovagen AB Antibody Development Services Product Offerings
Table 74. Innovagen AB Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 75. BIOTEM Corporate Summary
Table 76. BIOTEM Antibody Development Services Product Offerings
Table 77. BIOTEM Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 78. Medimab Corporate Summary
Table 79. Medimab Antibody Development Services Product Offerings
Table 80. Medimab Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 81. OriGene Corporate Summary
Table 82. OriGene Antibody Development Services Product Offerings
Table 83. OriGene Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 84. Abeomics Inc. Corporate Summary
Table 85. Abeomics Inc. Antibody Development Services Product Offerings
Table 86. Abeomics Inc. Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 87. RayBiotech Corporate Summary
Table 88. RayBiotech Antibody Development Services Product Offerings
Table 89. RayBiotech Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 90. Genscript Biotech Corporation Corporate Summary
Table 91. Genscript Biotech Corporation Antibody Development Services Product Offerings
Table 92. Genscript Biotech Corporation Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 93. Sino Biological Corporate Summary
Table 94. Sino Biological Antibody Development Services Product Offerings
Table 95. Sino Biological Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 96. Abzena Ltd Corporate Summary
Table 97. Abzena Ltd Antibody Development Services Product Offerings
Table 98. Abzena Ltd Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 99. Creative Biolabs Corporate Summary
Table 100. Creative Biolabs Antibody Development Services Product Offerings
Table 101. Creative Biolabs Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 102. Abcam Corporate Summary
Table 103. Abcam Antibody Development Services Product Offerings
Table 104. Abcam Antibody Development Services Revenue (US$, Mn), (2017-2022)
Table 105. Antibodies Incorporated Corporate Summary
Table 106. Antibodies Incorporated Antibody Development Services Product Offerings
Table 107. Antibodies Incorporated Antibody Development Services Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Antibody Development Services Segment by Type in 2021
Figure 2. Antibody Development Services Segment by Application in 2021
Figure 3. Global Antibody Development Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Antibody Development Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Antibody Development Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibody Development Services Revenue in 2021
Figure 8. By Type - Global Antibody Development Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Antibody Development Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Antibody Development Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Antibody Development Services Revenue Market Share, 2017-2028
Figure 12. US Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Antibody Development Services Revenue Market Share, 2017-2028
Figure 16. Germany Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Antibody Development Services Revenue Market Share, 2017-2028
Figure 24. China Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Antibody Development Services Revenue Market Share, 2017-2028
Figure 30. Brazil Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Antibody Development Services Revenue Market Share, 2017-2028
Figure 33. Turkey Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Antibody Development Services Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. R&D Systems Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Leinco Technologies Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Rockland Immunochemicals, Inc. (Rockland) Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bio-Rad Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioGenes Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. ProteoGenix Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Labcorp Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Inotiv, Inc. Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ProMab Biotechnologies Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Kemp Proteins Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Synaptic Systems Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. ARVYS Proteins, Inc. Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. BBI Solutions Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Innovagen AB Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. BIOTEM Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Medimab Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. OriGene Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Abeomics Inc. Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. RayBiotech Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Genscript Biotech Corporation Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Sino Biological Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Abzena Ltd Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Creative Biolabs Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Abcam Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Antibodies Incorporated Antibody Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications